MRMona Rabie

Mona Rabie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mona Rabie has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synergistic analgesia: ultrasound-guided continuous suprascapular nerve block combined with oral gabapentin in managing frozen shoulder pain

    by Lobna Ismaeil Kotb, Amr Shaaban Elshafei, Eslam N Nada, Mohamed Ibrahim, Mona Rabie

    Introduction: Adhesive capsulitis is a painful and disabling shoulder condition characterized by progressive restriction of both active and passive movements. Although suprascapular nerve block is widely used for pain control, optimal strategies to enhance and prolong its analgesic effect remain under investigation. This study aimed to evaluate the effectiveness of adding oral gabapentin to a continuous ultrasound-guided suprascapular nerve block in improving pain relief, range of motion, and patient satisfaction in individuals with frozen shoulder. Methodology: In this prospective randomized clinical trial, 40 patients with unilateral adhesive capsulitis unresponsive to conservative management were allocated into two equal groups. The control group received continuous ultrasound-guided suprascapular nerve block alone, while the gabapentin group received the same intervention combined with oral gabapentin 300 mg once daily. Pain intensity was assessed using the Visual Analog Scale at rest and during movement, and shoulder range of motion was measured using a goniometer before, one hour after maneuver, and every week for six-week follow-up period. Results: The VAS in Gabapentin Group during rest and active movements were statistically significantly lower than that in Control group from 1st week till 6th week. Also, the range of passive and active movement in Gabapentin Group was statistically significantly larger than that in Control from 1st week till 6th week. Patient satisfaction was notably higher in the gabapentin group. Conclusion: The addition of oral gabapentin to continuous suprascapular nerve block provides enhanced and sustained pain relief, improves functional outcomes, and increases patient satisfaction. This combined approach may represent a more effective strategy for managing refractory frozen shoulder and supporting rehabilitation.

  • Open Access

    Old marker, new face: anti-RNP as a sentinel of coronary and peripheral endothelial dysfunction in systemic lupus erythematosus

    by Amany M. Ebaid, Mona Rabie, Wedad Mahmoud Ghazy, Shaimaa Wageeh, Mohammad Eltahlawi, Doaa Alhssein Abo-Alella, Wafaa Metwally, Basma Magdy Elkholy, Lobna I Kotb

    Objective: To investigate the association between anti-ribonucleoprotein (anti-RNP) antibodies and endothelial dysfunction (ED) in patients with SLE and their ability to predict early ED manifestations, both coronary and peripherally. Methods: A cross-sectional study was conducted at a tertiary hospital involving 70 patients with SLE meeting American College of Rheumatology (ACR)/Systemic Lupus International Collaborating Clinics (SLICC) criteria. All study participants underwent a full clinical and laboratory evaluation, including testing for Cardiovascular Diseases serum anti-RNP antibodies. Conventional transthoracic 2-dimensional echocardiography, tissue Doppler imaging and a transthoracic dobutamine stress echocardiography to assess coronary microvasculature by measuring coronary flow velocity reserve (CFVR). Peripheral microvascular morphology was evaluated via nailfold dermoscopy. The primary outcome measures were the mean CFVR values and the presence of dermoscopic abnormalities (capillary drop-out, tortuosity and density) in relation to anti-RNP titres. Results: In 70 patients with SLE, those with high disease activity (n=45) exhibited significantly impaired cardiac function compared with low-activity patients (n=25), showing lower ejection fraction (EF) and CFVR, alongside higher Wall Motion Score Index (p<0.05). Anti-RNP levels correlated positively with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI, r=0.653, p<0.001), erythrocyte sedimentation rate, proteinuria and Raynaud’s phenomenon. Significant negative correlations existed between anti-RNP and stress EF (r=−0.33), CFVR (r=−0.30), C3 and C4 (p<0.05). Furthermore, elevated anti-RNP levels were significantly associated with clinical manifestations such as myositis and avascular necrosis, as well as dermoscopic microvascular changes, including microhaemorrhage and capillary dropouts (p<0.05). Conclusions: High anti-RNP titres are significantly associated with subclinical coronary microvascular impairment and peripheral capillary architectural changes in SLE. These results suggest that anti-RNP acts as a sentinel marker for early ED, providing potential for improved cardiovascular risk stratification independent of traditional risk factors.

  • Plasma Wnt7b protein in rheumatoid arthritis: Detection of interstitial lung disease

    by Mona Rabie, Hanaa I. Abd El-Hady, Dalia A. Ibrahim, Tarek H. Hassan, Enas I. Abdelhady


  • Damage accrual in Behçet disease: Behçet's Syndrome Overall Damage Index (BODI) versus Behçet's Disease Damage Index (BDI)

    by Rofaida A. Hassan, Enas I. Abdelhady, Mona Rabie, Doaa E. Kamal

    Objectives: To assess the validity of Behçet's Syndrome Overall Damage Index (BODI) and Behçet's Disease Damage Index (BDI) as tools for the detection of damage accrual in Behçet's patients compared to Vasculitis Damage Index (VDI). Also, to evaluate the correlation and the interclass correlation among the 3 indices to find out their consistency.Method: A prospective cohort study was carried out on 102 adult Behçet's disease (BD) patients who were diagnosed according to the International Study Group criteria for BD. Disease severity and organ damage were assessed for each patient by VDI, BDI and BODI at baseline and 1‐year follow‐up visits. Damage accrual for each index was defined when there was an increase of at least 1 point (∆ ≥ 1) among the baseline and the follow‐up visits.Results: Correlations among the 3 indices were significant, with (r = 0.835, P < 0.001) between VDI and BODI, (r = 0.835, P < 0.001) between VDI and BDI, and (r = 0.844, P < 0.001) between BODI and BDI scores. A highly significant positive correlation existed between the 3 indices and age and disease duration. In contrast, the correlation with the BD Current Activity Form was non‐significant, which indicates good discriminative validity of the 3 indices. Neuropsychiatric and ocular systems showed a strong interclass correlation among the 3 indices. Regarding detecting damage accrual, BDI was more sensitive than BODI and showed more agreement with VDI.Conclusion: BD damage indices, VDI, BODI and BDI, had good convergent and discriminative validity for the assessment of BD damage. BDI had more sensitivity than BODI to the detection of damage accrual.


  • Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS)

    by Enas I. Abdelhady, Mona Rabie, Rofaida A. Hassan

    Introduction SLE disease activity score (SLE-DAS) is a novel, rapid, continuous and comprehensive score that overcomes the drawbacks of SLEDAI-2 K. Low lupus disease activity state (LLDAS) has been targeted as an endpoint in many clinical trials and as a favourable outcome in clinical practice. Therefore, our objective in the current study is to evaluate the validity of SLE-DAS for defining LLDAS as an objective in the treat-to-target strategy. Methods A cross-sectional study was carried out on 117 SLE patients who were diagnosed according to Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for SLE. Patients were evaluated for disease activity by both SLEDAI-2 K and SLE-DAS. Additionally, patients were divided according to the SLEDAI-2 K-derived LLDAS definition into two groups: low disease activity (LDA) group and high disease activity (HDA) group. The validity of SLE-DAS for the definition of LLDAS was evaluated in comparison to SLEDAI-2 K. Results SLE-DAS shows highly significant positive correlation (r = 0.743, p < 0.001) with SLEDAI-2 K. The ROC curve revealed that SLE-DAS is valid for the assessment of activity with the best detection of LLDAS was at 6.62 with 95.5% sensitivity, 79.3% specificity and 89.6% accuracy. Moreover, it had a good agreement with the SLEDAI-2 K-derived definition of LLDAS (k = 0.765, p < 0.001). Conclusion SLE-DAS is a valid score for the definition of LLDAS which can be used in the clinical practice as a simple and precise standalone criterion. Key Points • Correlation between SLEDAI-2K and SLE-DAS revealed a high significance. • Identify SLE-DAS cut-off 6.62 for the definition of LLDAS. • There is a good agreement between SLEDAI-2K-derived definition of LLDAS and SLE-DAS definition.